[{"NetIncomeLoss_3_Q3_USD":-423139000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"MarketableSecuritiesCurrent_0_Q3_USD":312598000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":94909000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":36991000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":74925.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":75628.0,"CommitmentsAndContingencies_0_Q3_USD":null,"AccruedLiabilitiesCurrent_0_Q3_USD":60766000.0,"RestrictedCashCurrent_0_Q3_USD":1255000.0,"InterestPaidNet_3_Q3_USD":12929000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-1759000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-316898000.0,"Depreciation_3_Q3_USD":370000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":4633000.0,"AssetsCurrent_0_Q3_USD":742349000.0,"DerivativeGainLossOnDerivativeNet_3_Q3_USD":-62939000.0,"DerivativeGainLossOnDerivativeNet_1_Q3_USD":2697000.0,"PaymentsToAcquireAvailableForSaleSecurities_3_Q3_USD":567187000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":25784000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":25784000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":1127000.0,"ConvertibleDebtNoncurrent_0_Q3_USD":353769000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":4636000.0,"OperatingLeaseLiability_0_Q3_USD":19112000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":122000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-430000.0,"Liabilities_0_Q3_USD":662494000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":249584000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":93207000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":23097000.0,"IncreaseDecreaseInPrepaidExpense_3_Q3_USD":-8503000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_3_Q3_USD":255000000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":-1666000.0,"PrepaidExpenseCurrent_0_Q3_USD":11299000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":4047000.0,"ProceedsFromStockPlans_3_Q3_USD":521000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":4000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-16000.0,"CommonStockSharesIssued_0_Q3_shares":75700000.0,"CommonStockValue_0_Q3_USD":8000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":685861000.0,"RestrictedCash_0_Q3_USD":1255000.0,"InvestmentIncomeNonoperating_3_Q3_USD":3970000.0,"InvestmentIncomeNonoperating_1_Q3_USD":670000.0,"OtherAssetsCurrent_0_Q3_USD":1637000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-424744000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-137788000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":2392000.0,"OtherAssetsNoncurrent_0_Q3_USD":909000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":415560000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":15674000.0,"IncreaseDecreaseInOtherCurrentAssets_3_Q3_USD":627000.0,"IncreaseDecreaseInOtherNoncurrentAssets_3_Q3_USD":519000.0,"Assets_0_Q3_USD":768334000.0,"ShareBasedCompensation_3_Q3_USD":32882000.0,"CurrentIncomeTaxExpenseBenefit_1_Q3_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":64830000.0,"CommonStockSharesOutstanding_0_Q3_shares":75700000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":-1605000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":-2088000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":12099000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":-1727000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":-1658000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-302467000.0,"LongTermPurchaseCommitmentAmount_3_Q3_USD":3100000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":4759000.0,"LiabilitiesCurrent_0_Q3_USD":75273000.0,"AccountsPayableCurrent_0_Q3_USD":11069000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":416815000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":4155000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":8086000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.0784,"AdditionalPaidInCapital_0_Q3_USD":1112203000.0,"OperatingLeasePayments_3_Q3_USD":3322000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":6531000.0,"AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_1_Q3_USD":-1662000.0,"NetIncomeLoss_1_Q3_USD":-135700000.0,"CurrentIncomeTaxExpenseBenefit_3_Q3_USD":0.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-1004612000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":4711000.0,"StockholdersEquity_0_Q3_USD":105840000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":18545000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":381423000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":3985000.0,"CommonStockSharesAuthorized_0_Q3_shares":200000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":646000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":646000.0,"OperatingIncomeLoss_3_Q3_USD":-343847000.0,"OperatingIncomeLoss_1_Q3_USD":-129552000.0,"PreferredStockValue_0_Q3_USD":0.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":-2088000.0,"DeferredIncomeTaxExpenseBenefit_3_Q3_USD":0.0,"OperatingLeaseCost_3_Q3_USD":3100000.0,"OperatingLeaseCost_1_Q3_USD":1100000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":768334000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":3438000.0,"OperatingExpenses_3_Q3_USD":344493000.0,"OperatingExpenses_1_Q3_USD":130198000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":6664000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-5.65,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-1.79,"ProfitLoss_3_Q3_USD":-423139000.0,"DeferredIncomeTaxExpenseBenefit_1_Q3_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":1223000.0,"Ticker":"APLS","CIK":"1492422","name":"APELLIS PHARMACEUTICALS, INC.","OfficialName":"Apellis Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"5553923312.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201102"}]